Related Experiment Video
Updated: Jun 20, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Living related liver transplantation in Crigler-Najjar syndrome type 1
1Department of Pediatric Gastroenterology, Faculty of Medicine, Başkent University, Ankara, Turkey. figenoz@baskent-ank.edu.tr
Insights
Living related liver transplantation can cure Crigler-Najjar syndrome type 1. Early transplantation before neurologic dysfunction is crucial for normal neurodevelopmental outcomes in children.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Genetics
Background:
- Crigler-Najjar syndrome type 1 is a severe genetic disorder causing extreme hyperbilirubinemia.
- Infants with this condition are at high risk for bilirubin encephalopathy and neurological damage.
Purpose of the Study:
- To evaluate the efficacy of living related liver transplantation in treating Crigler-Najjar syndrome type 1 in children.
- To assess the impact of transplantation timing on neurodevelopmental outcomes.
Main Methods:
- Four children with Crigler-Najjar syndrome type 1 underwent living related liver transplantation.
- Pre- and post-transplantation bilirubin levels, clinical status, and neurodevelopmental milestones were monitored.
Main Results:
- Unconjugated bilirubin normalized within 24 hours post-transplantation in all patients.
- Three patients achieved normal neurodevelopmental milestones.
- One infant who developed suspected encephalopathy pre-transplantation experienced neurological decline and mortality.
Conclusions:
- Liver transplantation is a curative treatment for Crigler-Najjar syndrome type 1.
- Timely transplantation before the onset of neurological dysfunction is critical for favorable outcomes.
- Early detection and intervention are essential to prevent irreversible brain damage.
Abstract:
Four children underwent living related liver transplantation because of Crigler-Najjar syndrome type 1. Three were infants aged 2, 8(1/2), and 15 months, and weighed 5, 8, and 10 kg, respectively. Pretransplantation unconjugated bilirubin concentration was 22 to 30 mg/dL despite 12 to 14 hours of phototherapy daily. Patient 1, the 2-month-old infant, with unconjugated bilirubin concentration of 30 mg/dL, had a high-pitched cry, suggestive of bilirubin encephalopathy; results of neurologic examination were normal. Plasmapheresis and urgent liver transplantation were performed. Patient 4, a 13-year-old girl, had learning difficulties at school and attended a special class. Three patients received left lateral liver segments, and 1 patient received a left lobe. Biliary reconstruction was completed with duct-to-duct anastomosis. Bile leakage developed at the anastomosis in 2 patients, which was treated successfully with cholangioplasty. In all patients, the unconjugated bilirubin concentration normalized by day 1 posttransplantation, and no phototherapy was necessary. After transplantation, the 2-month-old infant with suspected encephalopathy exhibited hypotonia, spasticity of the lower extremities, and lack of head control. He died after vomitus aspiration during sleep at 10 months posttransplantation. The other 3 patients are alive with normal neurodevelopmental milestones. Irreversible brain damage may occur early in the course of Crigler-Najjar syndrome type 1. Urgent treatment including plasmapheresis, exchange transfusion, phototherapy, and liver transplantation may not reverse brain damage. Young infants must be evaluated carefully for subtle signs and symptoms of bilirubin encephalopathy. Liver transplantation is curative if performed before development of neurologic dysfunction.
Related Concept Videos
Kidney Transplant I: Introduction
Cirrhosis II: Pathophysiology
Kidney Transplant II: Surgical Procedure
Cirrhosis I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
